Research data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer

Company raises €12m in financing with a view to entering to the European market

Updated Date: Mon, 13 Mar 2023 00:00:00 EDT

Updated Date: Mon, 13 Mar 2023 00:00:00 EDT

When lymphatic vessels fail, typically their ability to pump out the fluid is compromised. Researchers have now developed […]

Company will also operate work on particular initiatives across an additional five neonatal sites

Combination therapy treat patients with metastatic castration-resistant prostate cancer

A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given […]

Updated Date: Fri, 10 Mar 2023 00:00:00 EST

Updated Date: Fri, 10 Mar 2023 00:00:00 EST